Comparable stake leader
Avoro Capital Advisors LLC
SEC ownership of Whitehawk Therapeutics, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001422142.
Disclosed value leader
Avoro Capital Advisors LLC
Comparable rows
50/50
Latest evidence
30 Jun 2026
- Public ticker
- WHWK on Nasdaq
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Avoro Capital Advisors LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Avoro Capital Advisors LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001422142
- Issuer location
- Morristown, NJ
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Whitehawk Therapeutics, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Avoro Capital Advisors LLC
Disclosed value leader
Avoro Capital Advisors LLC
Comparable rows
50/50
Latest evidence
30 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 20%
13D/G row: Avoro Capital Advisors LLC
Showing 1-8 of 50 holder rows.
Quick read
Avoro Capital Advisors LLC leads the comparable SEC ownership view at 20%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Avoro Capital Advisors LLC's linked filing trail.
Comparable ownership
Top 5
Avoro Capital Advisors LLC
20%
MONTANOVA CAPITAL, LLC
10%
ABG Management Ltd.
9.4%
QVT Financial LP
9.4%
ACUTA CAPITAL PARTNERS, LLC
9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Avoro Capital Advisors LLC |
13D/G
3/4/5
13F
Behzad Aghazadeh · Director, Other*, 10%+ Owner · Company
|
20%
|
$64,207,289
18,292,675 shares
|
+$22,385,776 | 12 May 2026 |
| MONTANOVA CAPITAL, LLC |
13F
13D/G
Company · SUVRETTA CAPITAL MANAGEMENT, LLC
|
10%
from 13D/G
|
$19,694,000
4,300,000 shares
|
— | 30 Jun 2026 |
| ABG Management Ltd. |
13D/G
Fan Yu
|
9.4%
|
$22,489,842
5,679,253 shares
|
+$10,948,006 | 30 Jun 2026 |
| QVT Financial LP |
13F
13D/G
Company
|
9.4%
from 13D/G
|
$21,139,947
4,615,709 shares
|
— | 30 Jun 2026 |
| ACUTA CAPITAL PARTNERS, LLC |
13F
13D/G
Company · ANUPAM DALAL
|
9%
from 13D/G
|
$21,461,477
4,685,912 shares
|
— | 30 Jun 2026 |
| ORBIMED ADVISORS LLC |
13F
13D/G
Company
|
7.3%
from 13D/G
|
$18,019,076
3,934,296 shares
|
— | 30 Jun 2026 |
| Coastlands Capital LP |
13D/G
|
6%
|
$5,074,587
2,819,215 shares
|
$0 | 19 Aug 2025 |
| BML Investment Partners, L.P. |
13D/G
Leonard Braden Michael
|
5%
|
$3,749,900
2,435,000 shares
|
-$331,178 | 05 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$2,584,560.
Buys
$0
Insiders: 0
Sells
$2,584,560
Insiders: 3
Net
-$2,584,560
Shares: -705,358
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 705,358
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 218,600 | $0 | $882,028 | -$882,028 |
| 6-9 | 0 | 486,758 | $0 | $1,702,532 | -$1,702,532 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 23 reporting-owner rows connected to Whitehawk Therapeutics, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
23
Largest Forms 3/4/5 holder
Anupam Dalal
Net 12M change
-$2,584,560
Latest report
15 Sep 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Anupam Dalal | Director | $20,669,854 | Mixed | 14 May 2026 | ||
| Behzad Aghazadeh | Director, Other*, 10%+ Owner | $19,998,367 | Mixed | 12 Jun 2026 | ||
| Caley Castelein | Director | $8,420,739 | Mixed | 12 Jun 2026 | ||
| David James Lennon | CHIEF EXECUTIVE OFFICER, Director | $3,827,255 | -$1,058,893 | -22% | Mixed | 15 Sep 2026 |
| Baiteng Zhao | Director | $3,000,000 | Mixed | 12 Jun 2026 | ||
| Bryan Ball | Chief Technical Operations Officer | $2,425,711 | -$635,054 | -21% | Mixed | 15 Sep 2026 |
| Scott M. Giacobello | Chief Financial Officer | $2,287,902 | -$890,613 | -28% | Mixed | 15 Sep 2026 |
| Neil Desai | Director | $2,000,878 | Filing P/S | 12 Jun 2026 | ||
| Margaret Dugan | Chief Medical Officer | $66,005 | Mixed | 15 Sep 2026 | ||
| Lorettta M. Itri | Chief Medical Officer | $52,335 | Mixed | 01 Mar 2024 | ||
| Steven Prelack | Director | $50,456 | Mixed | 30 Jun 2021 | ||
| Cheryl Cohen | Director | $33,301 | Mixed | 30 Jun 2021 | ||
| Pravin Dugel | Director | $25,899 | Mixed | 30 Jun 2021 | ||
| Lance E. Thibault | Chief Financial Officer | Mixed | 26 Aug 2021 | |||
| Brendan Delaney | President and Chief Executive Officer, Director | Mixed | 01 Mar 2023 | |||
| Karin M. Hehenberger | Director | Mixed | 12 Jun 2024 | |||
| Mohammad Hirmand | Director | Mixed | 12 Jun 2026 | |||
| Richard E. Maroun | Director | Mixed | 12 Jun 2026 | |||
| Emma Reeve | Director | Mixed | 12 Jun 2026 | |||
| David Dornan | Chief Scientific Officer | Mixed | 15 Sep 2026 |
Recent insider transactions for Whitehawk Therapeutics, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Scott M. Giacobello | WHWK | Restricted Stock Units | Award | 118,476 | 118,476 | 15 Sep 2026 | Direct | |||
| Scott M. Giacobello | WHWK | Stock Option (right to buy) | Award | 118,476 | 118,476 | 15 Sep 2026 | Direct | |||
| Bryan Ball | WHWK | Restricted Stock Units | Award | 91,633 | 91,633 | 15 Sep 2026 | Direct | |||
| Bryan Ball | WHWK | Stock Option (right to buy) | Award | 91,633 | 91,633 | 15 Sep 2026 | Direct | |||
| David Dornan | WHWK | Restricted Stock Units | Award | 85,887 | 85,887 | 15 Sep 2026 | Direct | |||
| David Dornan | WHWK | Stock Option (right to buy) | Award | 85,887 | 85,887 | 15 Sep 2026 | Direct | |||
| David James Lennon | WHWK | Restricted Stock Units | Award | 193,957 | 193,957 | 15 Sep 2026 | Direct | |||
| David James Lennon | WHWK | Stock option (right to buy) | Award | 193,957 | 193,957 | 15 Sep 2026 | Direct | |||
| Margaret Dugan | WHWK | Restricted Stock Units | Award | 81,250 | 81,250 | 15 Sep 2026 | Direct | |||
| Margaret Dugan | WHWK | Stock Option (right to buy) | Award | 81,250 | 81,250 | 15 Sep 2026 | Direct | |||
| Vijay K. Iyengar | WHWK | Stock Option (right to buy) | Award | 76,080 | 76,080 | 09 Sep 2026 | Direct | |||
| Anupam Dalal | WHWK | Stock Option (right to buy) | Award | 38,040 | 38,040 | 12 Jun 2026 | Direct | |||
| Baiteng Zhao | WHWK | Stock Option (right to buy) | Award | 38,040 | 38,040 | 12 Jun 2026 | Direct | |||
| Emma Reeve | WHWK | Stock Option (right to buy) | Award | 38,040 | 38,040 | 12 Jun 2026 | Direct | |||
| Richard E. Maroun | WHWK | Stock Option (right to buy) | Award | 38,040 | 38,040 | 12 Jun 2026 | Direct | |||
| Mohammad Hirmand | WHWK | Stock Option (right to buy) | Award | 38,040 | 38,040 | 12 Jun 2026 | Direct | |||
| Neil Desai | WHWK | Stock Option (right to buy) | Award | 38,040 | 38,040 | 12 Jun 2026 | Direct | |||
| Caley Castelein | WHWK | Stock Option (right to buy) | Award | 38,040 | 38,040 | 12 Jun 2026 | Direct | |||
| Aghazadeh Behzad | WHWK | Stock Option (right to buy) | Award | 38,040 | 38,040 | 12 Jun 2026 | Direct | |||
| Aghazadeh Behzad | WHWK | Stock Option (right to buy) | Award | 38,040 | 38,040 | 12 Jun 2026 | Direct | |||
| Behzad Aghazadeh | WHWK | Stock Option (right to buy) | Award | 38,040 | 38,040 | 12 Jun 2026 | Direct | |||
| Anupam Dalal | WHWK | Common Stock | Award | 37.4% | 1,275,510 | 4,685,912 | 14 May 2026 | See footnote | ||
| Margaret Dugan | WHWK | Common Stock | Award | 19,132 | 19,132 | 14 May 2026 | Direct | |||
| Bryan Ball | WHWK | Common Stock | Award | 12.8% | 51,020 | 448,126 | 14 May 2026 | Direct | ||
| Scott M. Giacobello | WHWK | Common Stock | Award | 13% | 38,265 | 333,489 | 14 May 2026 | Direct | ||
| David James Lennon | WHWK | Common Stock | Award | 9.84% | 51,021 | 569,643 | 14 May 2026 | Direct | ||
| Caley Castelein | WHWK | Common Stock | Award | 1295.3% | 255,102 | 274,796 | 14 May 2026 | Direct | ||
| Caley Castelein | WHWK | Pre-Funded Warrant (right to buy) | Award | 2,072,756 | 2,072,756 | 14 May 2026 | See footnote | |||
| Avoro Capital Advisors LLC | WHWK | Pre-funded Warrant (right to buy) | Award | 76.5% | 6,377,714 | 14,710,714 | 12 May 2026 | See footnotes | ||
| Avoro Capital Advisors LLC | WHWK | Pre-funded Warrant (right to buy) | Award | 76.5% | 6,377,714 | 14,710,714 | 12 May 2026 | See footnotes | ||
| Avoro Capital Advisors LLC | WHWK | Pre-funded Warrant (right to buy) | Award | 76.5% | 6,377,714 | 14,710,714 | 12 May 2026 | See footnotes | ||
| Scott M. Giacobello | WHWK | Common Stock | Sale | -32.4% | $584,808 | $4.13 | -141,600 | 295,224 | 16 Apr 2026 | Direct |
| Scott M. Giacobello | WHWK | Common Stock | Sale | -15% | $297,220 | $3.86 | -77,000 | 436,824 | 15 Apr 2026 | Direct |
| Bryan Ball | WHWK | Common Stock | Sale | -18.9% | $336,554 | $3.64 | -92,460 | 397,106 | 14 Apr 2026 | Direct |
| Bryan Ball | WHWK | Common Stock | Sale | -5.11% | $91,306 | $3.46 | -26,389 | 489,566 | 13 Apr 2026 | Direct |
| Bryan Ball | WHWK | Common Stock | Sale | -1.26% | $22,624 | $3.43 | -6,596 | 515,955 | 10 Apr 2026 | Direct |
| Bryan Ball | WHWK | Common Stock | Sale | -8.73% | $178,500 | $3.57 | -50,000 | 522,551 | 09 Apr 2026 | Direct |
| David James Lennon | WHWK | Common Stock | Sale | -2.72% | $49,010 | $3.38 | -14,500 | 518,622 | 09 Apr 2026 | Direct |
| David James Lennon | WHWK | Common Stock | Sale | -10.7% | $217,413 | $3.40 | -63,945 | 533,122 | 08 Apr 2026 | Direct |
| David James Lennon | WHWK | Common Stock | Sale | -13.6% | $322,718 | $3.43 | -94,087 | 597,067 | 07 Apr 2026 | Direct |
| David James Lennon | WHWK | Common Stock | Sale | -12.9% | $359,406 | $3.51 | -102,395 | 691,154 | 06 Apr 2026 | Direct |
| David James Lennon | WHWK | Common Stock | Sale | -3.27% | $93,466 | $3.48 | -26,858 | 793,549 | 02 Apr 2026 | Direct |
| David Dornan | WHWK | Stock Option (right to buy) | Award | 282,340 | 282,340 | 01 Apr 2026 | Direct | |||
| Margaret Dugan | WHWK | Stock Option (right to buy) | Award | 283,157 | 283,157 | 01 Apr 2026 | Direct | |||
| Bryan Ball | WHWK | Common Stock | Options Exercise | 177.9% | 366,532 | 572,551 | 01 Apr 2026 | Direct | ||
| Bryan Ball | WHWK | Stock Option (right to buy) | Award | 250,058 | 250,058 | 01 Apr 2026 | Direct | |||
| Bryan Ball | WHWK | Restricted Stock Units | Options Exercise | -100% | -366,532 | 0 | 01 Apr 2026 | Direct | ||
| Scott M. Giacobello | WHWK | Common Stock | Options Exercise | 1686.5% | 473,902 | 502,002 | 01 Apr 2026 | Direct | ||
| Scott M. Giacobello | WHWK | Stock Option (right to buy) | Award | 300,677 | 300,677 | 01 Apr 2026 | Direct | |||
| Scott M. Giacobello | WHWK | Restricted Stock Units | Options Exercise | -100% | -473,902 | 0 | 01 Apr 2026 | Direct |
* marks a reported price that did not pass the local price check.